Medicine & Health

The Undiagnosed Diseases Network at WashU Medicine plans to increase outreach to medically underserved communities and boost the number of patients seen.

Researchers at WashU have developed bioelectronic scaffolds in a unique way that creates new tissues.

WashU Medicine has launched the Center for Rare, Undiagnosed and Genetic Diseases, which brings together researchers and patient communities to create a collaborative network to drive innovative research and accelerate drug discovery.

Benjamin Garcia, the Raymond H. Wittcoff Distinguished Professor at WashU Medicine, along with colleagues Zongtao (Tom) Lin and Dongwen Lyu, received a four-year $2.4 million grant renewal from the National Heart, Lung and Blood Institute, part of the National Institutes of Health (NIH).

A recent study by WashU Medicine researchers found Black children were about half as likely as white children to obtain genetic testing ordered by their neurologists.

Heath Rutledge-Jukes, 25, a second-year student at WashU Medicine, has earned a spot on Forbes’ “30 Under 30” education list.

Neuroscientist Juliet Mwirigi, a postdoctoral researcher in the Department of Anesthesiology at WashU Medicine, has been named a Hanna H. Gray Fellow by the Howard Hughes Medical Institute.

WashU Olin Business School recently launched a new health initiative that envisions Olin as the premier institution for the business of health and an engine for innovation at WashU. 

WashU Medicine and the Weizmann Institute of Science have launched a collaboration to support joint research projects focused on understanding the role of microbes and the immune and nervous systems in human health and disease.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S.